Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-23

Clinical Trial Update: HMB and Exercise-induced Muscle Damage [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a phase 2/phase 3 study evaluating HMB supplementation on exercise-induced muscle damage and recovery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMB (beta-hydroxy beta-methylbutyrate)

Snippet

Sponsor: Poznan University of Physical Education | Conditions: Supplementation, Sport | Phase 2, Phase 3 | Status: RECRUITING